Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action

Matthew Hickman; Vivian Hope; Barbara Coleman; John Parry; Maggie Telfer; John Twigger; Charles Irish; John A A Macleod; Hugh Annett

doi:10.1093/pubmed/fdp067

Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action

Matthew Hickman, Vivian Hope, Barbara Coleman, John Parry, Maggie Telfer, John Twigger, Charles Irish, John A A Macleod, Hugh Annett

Research output: Contribution to journal › Article (Academic Journal) › peer-review

43 Citations (Scopus)

Abstract

BACKGROUND: We report on an exercise to estimate the prevalence of injecting drug use (IDU) and associated harms in a single primary care trust.

METHODS: Covariate capture-recapture methods to estimate (i) IDU prevalence; respondent driven sampling to measure (ii) prevalence of HCV and HIV and record linkage to measure (iii) mortality risk.

RESULTS: (i) The overall estimated number of IDU was 5540 (95% confidence interval, CI: 4710-6780) for all cases and 3280 (95% CI: 1940-4610) for cases matched to primary care register, i.e. a prevalence of 2.2 and 1.3% aged 15-54, respectively. (ii) The prevalence of HCV, hepatitis B and HIV was: 53, 32 and 0.7%. Over 70% of IDU in Bristol reported having at least one vaccination for HBV; more than half of those who were HCV positive were undiagnosed. (iii) The all-cause and overdose mortality rates for IDU were 0.75 and 0.4% respectively; and the standardized mortality ratio was 7.8 (95% CI: 5.4-10.8).

CONCLUSION: Locally specific and useful intelligence on injecting and its health consequence can be generated to inform local public health action, and may contribute information to validate national prevalence estimates.

Translated title of the contribution	Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action
Original language	English
Pages (from-to)	374-382
Number of pages	9
Journal	Journal of Public Health (United Kingdom)
Volume	31
Issue number	3
DOIs	https://doi.org/10.1093/pubmed/fdp067
Publication status	Published - Sept 2009

Bibliographical note

Publisher: Oxford University Press

Keywords

Adolescent
Adult
Age Distribution
Cause of Death
Cocaine-Related Disorders
Confidence Intervals
Crack Cocaine
Drug Overdose
Female
Great Britain
HIV Infections
Hepatitis B
Hepatitis C
Homeless Persons
Humans
Male
Middle Aged
Prevalence
Primary Health Care
Public Health
Risk Factors
Substance Abuse, Intravenous
Young Adult

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/pubmed/fdp067

http://jpubhealth.oxfordjournals.org/cgi/reprint/31/3/374

Handle.net

Persistent link

Cite this

Hickman, M., Hope, V., Coleman, B., Parry, J., Telfer, M., Twigger, J., Irish, C., Macleod, J. A. A., & Annett, H. (2009). Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. Journal of Public Health (United Kingdom), 31(3), 374-382. https://doi.org/10.1093/pubmed/fdp067

@article{072b3f9d9a87446195eff02c34a49ae0,

title = "Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action",

abstract = "BACKGROUND: We report on an exercise to estimate the prevalence of injecting drug use (IDU) and associated harms in a single primary care trust.METHODS: Covariate capture-recapture methods to estimate (i) IDU prevalence; respondent driven sampling to measure (ii) prevalence of HCV and HIV and record linkage to measure (iii) mortality risk.RESULTS: (i) The overall estimated number of IDU was 5540 (95% confidence interval, CI: 4710-6780) for all cases and 3280 (95% CI: 1940-4610) for cases matched to primary care register, i.e. a prevalence of 2.2 and 1.3% aged 15-54, respectively. (ii) The prevalence of HCV, hepatitis B and HIV was: 53, 32 and 0.7%. Over 70% of IDU in Bristol reported having at least one vaccination for HBV; more than half of those who were HCV positive were undiagnosed. (iii) The all-cause and overdose mortality rates for IDU were 0.75 and 0.4% respectively; and the standardized mortality ratio was 7.8 (95% CI: 5.4-10.8).CONCLUSION: Locally specific and useful intelligence on injecting and its health consequence can be generated to inform local public health action, and may contribute information to validate national prevalence estimates.",

keywords = "Adolescent, Adult, Age Distribution, Cause of Death, Cocaine-Related Disorders, Confidence Intervals, Crack Cocaine, Drug Overdose, Female, Great Britain, HIV Infections, Hepatitis B, Hepatitis C, Homeless Persons, Humans, Male, Middle Aged, Prevalence, Primary Health Care, Public Health, Risk Factors, Substance Abuse, Intravenous, Young Adult",

author = "Matthew Hickman and Vivian Hope and Barbara Coleman and John Parry and Maggie Telfer and John Twigger and Charles Irish and Macleod, {John A A} and Hugh Annett",

note = "Publisher: Oxford University Press",

year = "2009",

month = sep,

doi = "10.1093/pubmed/fdp067",

language = "English",

volume = "31",

pages = "374--382",

journal = "Journal of Public Health (United Kingdom)",

issn = "1741-3842",

publisher = "Oxford University Press",

number = "3",

}

Hickman, M, Hope, V, Coleman, B, Parry, J, Telfer, M, Twigger, J, Irish, C, Macleod, JAA & Annett, H 2009, 'Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action', Journal of Public Health (United Kingdom), vol. 31, no. 3, pp. 374-382. https://doi.org/10.1093/pubmed/fdp067

Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. / Hickman, Matthew; Hope, Vivian; Coleman, Barbara et al.
In: Journal of Public Health (United Kingdom), Vol. 31, No. 3, 09.2009, p. 374-382.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action

AU - Hickman, Matthew

AU - Hope, Vivian

AU - Coleman, Barbara

AU - Parry, John

AU - Telfer, Maggie

AU - Twigger, John

AU - Irish, Charles

AU - Macleod, John A A

AU - Annett, Hugh

N1 - Publisher: Oxford University Press

PY - 2009/9

Y1 - 2009/9

N2 - BACKGROUND: We report on an exercise to estimate the prevalence of injecting drug use (IDU) and associated harms in a single primary care trust.METHODS: Covariate capture-recapture methods to estimate (i) IDU prevalence; respondent driven sampling to measure (ii) prevalence of HCV and HIV and record linkage to measure (iii) mortality risk.RESULTS: (i) The overall estimated number of IDU was 5540 (95% confidence interval, CI: 4710-6780) for all cases and 3280 (95% CI: 1940-4610) for cases matched to primary care register, i.e. a prevalence of 2.2 and 1.3% aged 15-54, respectively. (ii) The prevalence of HCV, hepatitis B and HIV was: 53, 32 and 0.7%. Over 70% of IDU in Bristol reported having at least one vaccination for HBV; more than half of those who were HCV positive were undiagnosed. (iii) The all-cause and overdose mortality rates for IDU were 0.75 and 0.4% respectively; and the standardized mortality ratio was 7.8 (95% CI: 5.4-10.8).CONCLUSION: Locally specific and useful intelligence on injecting and its health consequence can be generated to inform local public health action, and may contribute information to validate national prevalence estimates.

AB - BACKGROUND: We report on an exercise to estimate the prevalence of injecting drug use (IDU) and associated harms in a single primary care trust.METHODS: Covariate capture-recapture methods to estimate (i) IDU prevalence; respondent driven sampling to measure (ii) prevalence of HCV and HIV and record linkage to measure (iii) mortality risk.RESULTS: (i) The overall estimated number of IDU was 5540 (95% confidence interval, CI: 4710-6780) for all cases and 3280 (95% CI: 1940-4610) for cases matched to primary care register, i.e. a prevalence of 2.2 and 1.3% aged 15-54, respectively. (ii) The prevalence of HCV, hepatitis B and HIV was: 53, 32 and 0.7%. Over 70% of IDU in Bristol reported having at least one vaccination for HBV; more than half of those who were HCV positive were undiagnosed. (iii) The all-cause and overdose mortality rates for IDU were 0.75 and 0.4% respectively; and the standardized mortality ratio was 7.8 (95% CI: 5.4-10.8).CONCLUSION: Locally specific and useful intelligence on injecting and its health consequence can be generated to inform local public health action, and may contribute information to validate national prevalence estimates.

KW - Adolescent

KW - Adult

KW - Age Distribution

KW - Cause of Death

KW - Cocaine-Related Disorders

KW - Confidence Intervals

KW - Crack Cocaine

KW - Drug Overdose

KW - Female

KW - Great Britain

KW - HIV Infections

KW - Hepatitis B

KW - Hepatitis C

KW - Homeless Persons

KW - Humans

KW - Male

KW - Middle Aged

KW - Prevalence

KW - Primary Health Care

KW - Public Health

KW - Risk Factors

KW - Substance Abuse, Intravenous

KW - Young Adult

U2 - 10.1093/pubmed/fdp067

DO - 10.1093/pubmed/fdp067

M3 - Article (Academic Journal)

C2 - 19596666

SN - 1741-3842

VL - 31

SP - 374

EP - 382

JO - Journal of Public Health (United Kingdom)

JF - Journal of Public Health (United Kingdom)

IS - 3

ER -

Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this